168 related articles for article (PubMed ID: 36471347)
1. TRIM56 promotes malignant progression of glioblastoma by stabilizing cIAP1 protein.
Yang X; Zhang Y; Xue Z; Hu Y; Zhou W; Xue Z; Liu X; Liu G; Li W; Liu X; Li X; Han M; Wang J
J Exp Clin Cancer Res; 2022 Dec; 41(1):336. PubMed ID: 36471347
[TBL] [Abstract][Full Text] [Related]
2. TRIM56 Reduces Radiosensitization of Human Glioblastoma by Regulating FOXM1-Mediated DNA Repair.
Dong Y; Xiong Y; Zhou D; Yao M; Wang X; Bi W; Zhang J
Mol Neurobiol; 2022 Sep; 59(9):5312-5325. PubMed ID: 35696011
[TBL] [Abstract][Full Text] [Related]
3. TRIM56: a promising prognostic immune biomarker for glioma revealed by pan-cancer and single-cell analysis.
Wang B; Wang Z; Li Y; Shang Z; Liu Z; Fan H; Zhan R; Xin T
Front Immunol; 2024; 15():1327898. PubMed ID: 38348047
[TBL] [Abstract][Full Text] [Related]
4. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
5. TRIM25 promotes glioblastoma cell growth and invasion via regulation of the PRMT1/c-MYC pathway by targeting the splicing factor NONO.
Chen Y; Xu X; Ding K; Tang T; Cai F; Zhang H; Chen Z; Qi Y; Fu Z; Zhu G; Dou Z; Xu J; Chen G; Wu Q; Ji J; Zhang J
J Exp Clin Cancer Res; 2024 Feb; 43(1):39. PubMed ID: 38303029
[TBL] [Abstract][Full Text] [Related]
6. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
8. MiR-9 promotes multiple myeloma progression by regulating TRIM56/NF-κB pathway.
Huang G; Liu X; Zhao X; Zhao J; Hao J; Ren J; Chen Y
Cell Biol Int; 2019 Nov; 43(11):1223-1233. PubMed ID: 30637864
[TBL] [Abstract][Full Text] [Related]
9. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
[TBL] [Abstract][Full Text] [Related]
10. TRIM56 suppresses the malignant development of hepatocellular carcinoma via targeting RBM24 and inactivating the Wnt signaling.
Yang Y; Mao FF; Guo L; Guo WX
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):722-730. PubMed ID: 33577026
[TBL] [Abstract][Full Text] [Related]
11. TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling.
Chen Y; Zhao J; Li D; Hao J; He P; Wang H; Zhang M
Yonsei Med J; 2018 Jan; 59(1):43-50. PubMed ID: 29214775
[TBL] [Abstract][Full Text] [Related]
12. TRIM56 acts through the IQGAP1-CDC42 signaling axis to promote glioma cell migration and invasion.
Zhang Q; Zheng J; Wu W; Lian H; Iranzad N; Wang E; Yang L; Wang X; Jiang X
Cell Death Dis; 2023 Mar; 14(3):178. PubMed ID: 36870986
[TBL] [Abstract][Full Text] [Related]
13. The Functions of TRIM56 in Antiviral Innate Immunity and Tumorigenesis.
Fu L; Zhou X; Jiao Q; Chen X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902478
[TBL] [Abstract][Full Text] [Related]
14. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circ_0001588 sponges miR-211-5p to facilitate the progression of glioblastoma via up-regulating YY1 expression.
Wang Q; Zheng D; Li Y; Zhang Y; Sui R; Chen Y; Liang H; Shi J; Pan R; Xu X; Sun D
J Gene Med; 2021 Oct; 23(10):e3371. PubMed ID: 34105224
[TBL] [Abstract][Full Text] [Related]
16. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
17. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
19. Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis.
Xu T; Zhou Q; Zhou J; Huang Y; Yan Y; Li W; Wang C; Hu G; Lu Y; Chen J
Cancer Sci; 2011 May; 102(5):959-66. PubMed ID: 21272160
[TBL] [Abstract][Full Text] [Related]
20. PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/β-catenin axis.
Deng Q; Hou J; Feng L; Lv A; Ke X; Liang H; Wang F; Zhang K; Chen K; Cui H
Cell Death Dis; 2018 Oct; 9(11):1049. PubMed ID: 30323224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
